The global Pediatric Medicines market was valued at US$ 102110 million in 2023 and is anticipated to reach US$ 136060 million by 2030, witnessing a CAGR of 4.1% during the forecast period 2024-2030.

Pediatric Medicines Market

The pediatric drug market plays a pivotal role in the pharmaceutical industry.

The pediatric medicines market identifies the formulatory advancement as one of the primary factors for this market’s growth.

This report aims to provide a comprehensive presentation of the global market for Pediatric Medicines, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Pediatric Medicines.

Report Scope

The Pediatric Medicines market size, estimations, and forecasts are provided in terms of sales volume (Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Pediatric Medicines market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Pediatric Medicines manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Pediatric Medicines Market Report

Report Metric	Details
Report Name	Pediatric Medicines Market
Accounted market size in 2023	US$ 102110 million
Forecasted market size in 2030	US$ 136060 million
CAGR	4.1%
Base Year	2023
Forecasted years	2024 - 2030
Segment by Type	Enteral Parenteral Topical
Segment by Application	Hospital Clinic Family
Consumption by Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Asia-Pacific (China, Japan, South Korea, Taiwan) Southeast Asia (India) Latin America (Mexico, Brazil)
By Company	GSK, Novartis, Pfizer, Sanofi, Abbott, Bristol-Myers Squibb, Cipla, Eisai Pharmaceuticals, Eli Lilly, F. Hoffman-La Roche, Glenmark, Helsinn Healthcare, Heron Therapeutics, Ipca Laboratories
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Pediatric Medicines manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Pediatric Medicines in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

FAQ for this report

How fast is Pediatric Medicines Market growing?

Ans: The Pediatric Medicines Market witnessing a CAGR of 4.1% during the forecast period 2024-2030.

What is the Pediatric Medicines Market size in 2030?

Ans: The Pediatric Medicines Market size in 2030 will be US$ 136060 million.

Who are the main players in the Pediatric Medicines Market report?

Ans: The main players in the Pediatric Medicines Market are GSK, Novartis, Pfizer, Sanofi, Abbott, Bristol-Myers Squibb, Cipla, Eisai Pharmaceuticals, Eli Lilly, F. Hoffman-La Roche, Glenmark, Helsinn Healthcare, Heron Therapeutics, Ipca Laboratories

What are the Application segmentation covered in the Pediatric Medicines Market report?

Ans: The Applications covered in the Pediatric Medicines Market report are Hospital, Clinic, Family

What are the Type segmentation covered in the Pediatric Medicines Market report?

Ans: The Types covered in the Pediatric Medicines Market report are Enteral, Parenteral, Topical

1 Pediatric Medicines Market Overview

1.1 Product Overview and Scope of Pediatric Medicines

1.2 Pediatric Medicines Segment by Type

1.2.1 Global Pediatric Medicines Market Value Comparison by Type (2024-2030)

1.2.2 Enteral

1.2.3 Parenteral

1.2.4 Topical

1.3 Pediatric Medicines Segment by Application

1.3.1 Global Pediatric Medicines Market Value by Application: (2024-2030)

1.3.2 Hospital

1.3.3 Clinic

1.3.4 Family

1.4 Global Pediatric Medicines Market Size Estimates and Forecasts

1.4.1 Global Pediatric Medicines Revenue 2019-2030

1.4.2 Global Pediatric Medicines Sales 2019-2030

1.4.3 Global Pediatric Medicines Market Average Price (2019-2030)

1.5 Assumptions and Limitations

2 Pediatric Medicines Market Competition by Manufacturers

2.1 Global Pediatric Medicines Sales Market Share by Manufacturers (2019-2024)

2.2 Global Pediatric Medicines Revenue Market Share by Manufacturers (2019-2024)

2.3 Global Pediatric Medicines Average Price by Manufacturers (2019-2024)

2.4 Global Pediatric Medicines Industry Ranking 2022 VS 2023 VS 2024

2.5 Global Key Manufacturers of Pediatric Medicines, Manufacturing Sites & Headquarters

2.6 Global Key Manufacturers of Pediatric Medicines, Product Type & Application

2.7 Pediatric Medicines Market Competitive Situation and Trends

2.7.1 Pediatric Medicines Market Concentration Rate

2.7.2 The Global Top 5 and Top 10 Largest Pediatric Medicines Players Market Share by Revenue

2.7.3 Global Pediatric Medicines Market Share by Company Type (Tier 1, Tier 2 and Tier 3)

2.8 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Pediatric Medicines Retrospective Market Scenario by Region

3.1 Global Pediatric Medicines Market Size by Region: 2019 Versus 2023 Versus 2030

3.2 Global Pediatric Medicines Global Pediatric Medicines Sales by Region: 2019-2030

3.2.1 Global Pediatric Medicines Sales by Region: 2019-2024

3.2.2 Global Pediatric Medicines Sales by Region: 2025-2030

3.3 Global Pediatric Medicines Global Pediatric Medicines Revenue by Region: 2019-2030

3.3.1 Global Pediatric Medicines Revenue by Region: 2019-2024

3.3.2 Global Pediatric Medicines Revenue by Region: 2025-2030

3.4 North America Pediatric Medicines Market Facts & Figures by Country

3.4.1 North America Pediatric Medicines Market Size by Country: 2019 VS 2023 VS 2030

3.4.2 North America Pediatric Medicines Sales by Country (2019-2030)

3.4.3 North America Pediatric Medicines Revenue by Country (2019-2030)

3.4.4 U.S.

3.4.5 Canada

3.5 Europe Pediatric Medicines Market Facts & Figures by Country

3.5.1 Europe Pediatric Medicines Market Size by Country: 2019 VS 2023 VS 2030

3.5.2 Europe Pediatric Medicines Sales by Country (2019-2030)

3.5.3 Europe Pediatric Medicines Revenue by Country (2019-2030)

3.5.4 Germany

3.5.5 France

3.5.6 U.K.

3.5.7 Italy

3.5.8 Russia

3.6 Asia Pacific Pediatric Medicines Market Facts & Figures by Country

3.6.1 Asia Pacific Pediatric Medicines Market Size by Country: 2019 VS 2023 VS 2030

3.6.2 Asia Pacific Pediatric Medicines Sales by Country (2019-2030)

3.6.3 Asia Pacific Pediatric Medicines Revenue by Country (2019-2030)

3.6.4 China

3.6.5 Japan

3.6.6 South Korea

3.6.7 India

3.6.8 Australia

3.6.9 Taiwan

3.6.10 Indonesia

3.6.11 Thailand

3.6.12 Malaysia

3.6.13 Philippines

3.7 Latin America Pediatric Medicines Market Facts & Figures by Country

3.7.1 Latin America Pediatric Medicines Market Size by Country: 2019 VS 2023 VS 2030

3.7.2 Latin America Pediatric Medicines Sales by Country (2019-2030)

3.7.3 Latin America Pediatric Medicines Revenue by Country (2019-2030)

3.7.4 Mexico

3.7.5 Brazil

3.7.6 Argentina

3.8 Middle East and Africa Pediatric Medicines Market Facts & Figures by Country

3.8.1 Middle East and Africa Pediatric Medicines Market Size by Country: 2019 VS 2023 VS 2030

3.8.2 Middle East and Africa Pediatric Medicines Sales by Country (2019-2030)

3.8.3 Middle East and Africa Pediatric Medicines Revenue by Country (2019-2030)

3.8.4 Turkey

3.8.5 Saudi Arabia

3.8.6 UAE

4 Segment by Type

4.1 Global Pediatric Medicines Sales by Type (2019-2030)

4.1.1 Global Pediatric Medicines Sales by Type (2019-2024)

4.1.2 Global Pediatric Medicines Sales by Type (2025-2030)

4.1.3 Global Pediatric Medicines Sales Market Share by Type (2019-2030)

4.2 Global Pediatric Medicines Revenue by Type (2019-2030)

4.2.1 Global Pediatric Medicines Revenue by Type (2019-2024)

4.2.2 Global Pediatric Medicines Revenue by Type (2025-2030)

4.2.3 Global Pediatric Medicines Revenue Market Share by Type (2019-2030)

4.3 Global Pediatric Medicines Price by Type (2019-2030)

5 Segment by Application

5.1 Global Pediatric Medicines Sales by Application (2019-2030)

5.1.1 Global Pediatric Medicines Sales by Application (2019-2024)

5.1.2 Global Pediatric Medicines Sales by Application (2025-2030)

5.1.3 Global Pediatric Medicines Sales Market Share by Application (2019-2030)

5.2 Global Pediatric Medicines Revenue by Application (2019-2030)

5.2.1 Global Pediatric Medicines Revenue by Application (2019-2024)

5.2.2 Global Pediatric Medicines Revenue by Application (2025-2030)

5.2.3 Global Pediatric Medicines Revenue Market Share by Application (2019-2030)

5.3 Global Pediatric Medicines Price by Application (2019-2030)

6 Key Companies Profiled

6.1 GSK

6.1.1 GSK Corporation Information

6.1.2 GSK Description and Business Overview

6.1.3 GSK Pediatric Medicines Sales, Revenue and Gross Margin (2019-2024)

6.1.4 GSK Pediatric Medicines Product Portfolio

6.1.5 GSK Recent Developments/Updates

6.2 Novartis

6.2.1 Novartis Corporation Information

6.2.2 Novartis Description and Business Overview

6.2.3 Novartis Pediatric Medicines Sales, Revenue and Gross Margin (2019-2024)

6.2.4 Novartis Pediatric Medicines Product Portfolio

6.2.5 Novartis Recent Developments/Updates

6.3 Pfizer

6.3.1 Pfizer Corporation Information

6.3.2 Pfizer Description and Business Overview

6.3.3 Pfizer Pediatric Medicines Sales, Revenue and Gross Margin (2019-2024)

6.3.4 Pfizer Pediatric Medicines Product Portfolio

6.3.5 Pfizer Recent Developments/Updates

6.4 Sanofi

6.4.1 Sanofi Corporation Information

6.4.2 Sanofi Description and Business Overview

6.4.3 Sanofi Pediatric Medicines Sales, Revenue and Gross Margin (2019-2024)

6.4.4 Sanofi Pediatric Medicines Product Portfolio

6.4.5 Sanofi Recent Developments/Updates

6.5 Abbott

6.5.1 Abbott Corporation Information

6.5.2 Abbott Description and Business Overview

6.5.3 Abbott Pediatric Medicines Sales, Revenue and Gross Margin (2019-2024)

6.5.4 Abbott Pediatric Medicines Product Portfolio

6.5.5 Abbott Recent Developments/Updates

6.6 Bristol-Myers Squibb

6.6.1 Bristol-Myers Squibb Corporation Information

6.6.2 Bristol-Myers Squibb Description and Business Overview

6.6.3 Bristol-Myers Squibb Pediatric Medicines Sales, Revenue and Gross Margin (2019-2024)

6.6.4 Bristol-Myers Squibb Pediatric Medicines Product Portfolio

6.6.5 Bristol-Myers Squibb Recent Developments/Updates

6.7 Cipla

6.6.1 Cipla Corporation Information

6.6.2 Cipla Description and Business Overview

6.6.3 Cipla Pediatric Medicines Sales, Revenue and Gross Margin (2019-2024)

6.4.4 Cipla Pediatric Medicines Product Portfolio

6.7.5 Cipla Recent Developments/Updates

6.8 Eisai Pharmaceuticals

6.8.1 Eisai Pharmaceuticals Corporation Information

6.8.2 Eisai Pharmaceuticals Description and Business Overview

6.8.3 Eisai Pharmaceuticals Pediatric Medicines Sales, Revenue and Gross Margin (2019-2024)

6.8.4 Eisai Pharmaceuticals Pediatric Medicines Product Portfolio

6.8.5 Eisai Pharmaceuticals Recent Developments/Updates

6.9 Eli Lilly

6.9.1 Eli Lilly Corporation Information

6.9.2 Eli Lilly Description and Business Overview

6.9.3 Eli Lilly Pediatric Medicines Sales, Revenue and Gross Margin (2019-2024)

6.9.4 Eli Lilly Pediatric Medicines Product Portfolio

6.9.5 Eli Lilly Recent Developments/Updates

6.10 F. Hoffman-La Roche

6.10.1 F. Hoffman-La Roche Corporation Information

6.10.2 F. Hoffman-La Roche Description and Business Overview

6.10.3 F. Hoffman-La Roche Pediatric Medicines Sales, Revenue and Gross Margin (2019-2024)

6.10.4 F. Hoffman-La Roche Pediatric Medicines Product Portfolio

6.10.5 F. Hoffman-La Roche Recent Developments/Updates

6.11 Glenmark

6.11.1 Glenmark Corporation Information

6.11.2 Glenmark Pediatric Medicines Description and Business Overview

6.11.3 Glenmark Pediatric Medicines Sales, Revenue and Gross Margin (2019-2024)

6.11.4 Glenmark Pediatric Medicines Product Portfolio

6.11.5 Glenmark Recent Developments/Updates

6.12 Helsinn Healthcare

6.12.1 Helsinn Healthcare Corporation Information

6.12.2 Helsinn Healthcare Pediatric Medicines Description and Business Overview

6.12.3 Helsinn Healthcare Pediatric Medicines Sales, Revenue and Gross Margin (2019-2024)

6.12.4 Helsinn Healthcare Pediatric Medicines Product Portfolio

6.12.5 Helsinn Healthcare Recent Developments/Updates

6.13 Heron Therapeutics

6.13.1 Heron Therapeutics Corporation Information

6.13.2 Heron Therapeutics Pediatric Medicines Description and Business Overview

6.13.3 Heron Therapeutics Pediatric Medicines Sales, Revenue and Gross Margin (2019-2024)

6.13.4 Heron Therapeutics Pediatric Medicines Product Portfolio

6.13.5 Heron Therapeutics Recent Developments/Updates

6.14 Ipca Laboratories

6.14.1 Ipca Laboratories Corporation Information

6.14.2 Ipca Laboratories Pediatric Medicines Description and Business Overview

6.14.3 Ipca Laboratories Pediatric Medicines Sales, Revenue and Gross Margin (2019-2024)

6.14.4 Ipca Laboratories Pediatric Medicines Product Portfolio

6.14.5 Ipca Laboratories Recent Developments/Updates

7 Industry Chain and Sales Channels Analysis

7.1 Pediatric Medicines Industry Chain Analysis

7.2 Pediatric Medicines Key Raw Materials

7.2.1 Key Raw Materials

7.2.2 Raw Materials Key Suppliers

7.3 Pediatric Medicines Production Mode & Process

7.4 Pediatric Medicines Sales and Marketing

7.4.1 Pediatric Medicines Sales Channels

7.4.2 Pediatric Medicines Distributors

7.5 Pediatric Medicines Customers

8 Pediatric Medicines Market Dynamics

8.1 Pediatric Medicines Industry Trends

8.2 Pediatric Medicines Market Drivers

8.3 Pediatric Medicines Market Challenges

8.4 Pediatric Medicines Market Restraints

9 Research Finding and Conclusion

10 Methodology and Data Source

10.1 Methodology/Research Approach

10.1.1 Research Programs/Design

10.1.2 Market Size Estimation

10.1.3 Market Breakdown and Data Triangulation

10.2 Data Source

10.2.1 Secondary Sources

10.2.2 Primary Sources

10.3 Author List

10.4 Disclaimer

FEATURED COMPANIES

Eisai Pharmaceuticals

List of Tables

Table 1. Global Pediatric Medicines Market Value Comparison by Type (2024-2030) & (US$ Million)

Table 2. Global Pediatric Medicines Market Value Comparison by Application (2024-2030) & (US$ Million)

Table 3. Global Pediatric Medicines Market Competitive Situation by Manufacturers in 2023

Table 4. Global Pediatric Medicines Sales (Units) of Key Manufacturers (2019-2024)

Table 5. Global Pediatric Medicines Sales Market Share by Manufacturers (2019-2024)

Table 6. Global Pediatric Medicines Revenue (US$ Million) by Manufacturers (2019-2024)

Table 7. Global Pediatric Medicines Revenue Share by Manufacturers (2019-2024)

Table 8. Global Market Pediatric Medicines Average Price (USD/Unit) of Key Manufacturers (2019-2024)

Table 9. Global Key Players of Pediatric Medicines, Industry Ranking, 2022 VS 2023 VS 2024

Table 10. Global Key Manufacturers of Pediatric Medicines, Manufacturing Sites & Headquarters

Table 11. Global Key Manufacturers of Pediatric Medicines, Product Type & Application

Table 12. Global Key Manufacturers of Pediatric Medicines, Date of Enter into This Industry

Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Pediatric Medicines by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pediatric Medicines as of 2023)

Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 16. Global Pediatric Medicines Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Table 17. Global Pediatric Medicines Sales by Region (2019-2024) & (Units)

Table 18. Global Pediatric Medicines Sales Market Share by Region (2019-2024)

Table 19. Global Pediatric Medicines Sales by Region (2025-2030) & (Units)

Table 20. Global Pediatric Medicines Sales Market Share by Region (2025-2030)

Table 21. Global Pediatric Medicines Revenue by Region (2019-2024) & (US$ Million)

Table 22. Global Pediatric Medicines Revenue Market Share by Region (2019-2024)

Table 23. Global Pediatric Medicines Revenue by Region (2025-2030) & (US$ Million)

Table 24. Global Pediatric Medicines Revenue Market Share by Region (2025-2030)

Table 25. North America Pediatric Medicines Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 26. North America Pediatric Medicines Sales by Country (2019-2024) & (Units)

Table 27. North America Pediatric Medicines Sales by Country (2025-2030) & (Units)

Table 28. North America Pediatric Medicines Revenue by Country (2019-2024) & (US$ Million)

Table 29. North America Pediatric Medicines Revenue by Country (2025-2030) & (US$ Million)

Table 30. Europe Pediatric Medicines Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 31. Europe Pediatric Medicines Sales by Country (2019-2024) & (Units)

Table 32. Europe Pediatric Medicines Sales by Country (2025-2030) & (Units)

Table 33. Europe Pediatric Medicines Revenue by Country (2019-2024) & (US$ Million)

Table 34. Europe Pediatric Medicines Revenue by Country (2025-2030) & (US$ Million)

Table 35. Asia Pacific Pediatric Medicines Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)

Table 36. Asia Pacific Pediatric Medicines Sales by Region (2019-2024) & (Units)

Table 37. Asia Pacific Pediatric Medicines Sales by Region (2025-2030) & (Units)

Table 38. Asia Pacific Pediatric Medicines Revenue by Region (2019-2024) & (US$ Million)

Table 39. Asia Pacific Pediatric Medicines Revenue by Region (2025-2030) & (US$ Million)

Table 40. Latin America Pediatric Medicines Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 41. Latin America Pediatric Medicines Sales by Country (2019-2024) & (Units)

Table 42. Latin America Pediatric Medicines Sales by Country (2025-2030) & (Units)

Table 43. Latin America Pediatric Medicines Revenue by Country (2019-2024) & (US$ Million)

Table 44. Latin America Pediatric Medicines Revenue by Country (2025-2030) & (US$ Million)

Table 45. Middle East & Africa Pediatric Medicines Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 46. Middle East & Africa Pediatric Medicines Sales by Country (2019-2024) & (Units)

Table 47. Middle East & Africa Pediatric Medicines Sales by Country (2025-2030) & (Units)

Table 48. Middle East & Africa Pediatric Medicines Revenue by Country (2019-2024) & (US$ Million)

Table 49. Middle East & Africa Pediatric Medicines Revenue by Country (2025-2030) & (US$ Million)

Table 50. Global Pediatric Medicines Sales (Units) by Type (2019-2024)

Table 51. Global Pediatric Medicines Sales (Units) by Type (2025-2030)

Table 52. Global Pediatric Medicines Sales Market Share by Type (2019-2024)

Table 53. Global Pediatric Medicines Sales Market Share by Type (2025-2030)

Table 54. Global Pediatric Medicines Revenue (US$ Million) by Type (2019-2024)

Table 55. Global Pediatric Medicines Revenue (US$ Million) by Type (2025-2030)

Table 56. Global Pediatric Medicines Revenue Market Share by Type (2019-2024)

Table 57. Global Pediatric Medicines Revenue Market Share by Type (2025-2030)

Table 58. Global Pediatric Medicines Price (USD/Unit) by Type (2019-2024)

Table 59. Global Pediatric Medicines Price (USD/Unit) by Type (2025-2030)

Table 60. Global Pediatric Medicines Sales (Units) by Application (2019-2024)

Table 61. Global Pediatric Medicines Sales (Units) by Application (2025-2030)

Table 62. Global Pediatric Medicines Sales Market Share by Application (2019-2024)

Table 63. Global Pediatric Medicines Sales Market Share by Application (2025-2030)

Table 64. Global Pediatric Medicines Revenue (US$ Million) by Application (2019-2024)

Table 65. Global Pediatric Medicines Revenue (US$ Million) by Application (2025-2030)

Table 66. Global Pediatric Medicines Revenue Market Share by Application (2019-2024)

Table 67. Global Pediatric Medicines Revenue Market Share by Application (2025-2030)

Table 68. Global Pediatric Medicines Price (USD/Unit) by Application (2019-2024)

Table 69. Global Pediatric Medicines Price (USD/Unit) by Application (2025-2030)

Table 70. GSK Corporation Information

Table 71. GSK Description and Business Overview

Table 72. GSK Pediatric Medicines Sales (Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 73. GSK Pediatric Medicines Product

Table 74. GSK Recent Developments/Updates

Table 75. Novartis Corporation Information

Table 76. Novartis Description and Business Overview

Table 77. Novartis Pediatric Medicines Sales (Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 78. Novartis Pediatric Medicines Product

Table 79. Novartis Recent Developments/Updates

Table 80. Pfizer Corporation Information

Table 81. Pfizer Description and Business Overview

Table 82. Pfizer Pediatric Medicines Sales (Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 83. Pfizer Pediatric Medicines Product

Table 84. Pfizer Recent Developments/Updates

Table 85. Sanofi Corporation Information

Table 86. Sanofi Description and Business Overview

Table 87. Sanofi Pediatric Medicines Sales (Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 88. Sanofi Pediatric Medicines Product

Table 89. Sanofi Recent Developments/Updates

Table 90. Abbott Corporation Information

Table 91. Abbott Description and Business Overview

Table 92. Abbott Pediatric Medicines Sales (Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 93. Abbott Pediatric Medicines Product

Table 94. Abbott Recent Developments/Updates

Table 95. Bristol-Myers Squibb Corporation Information

Table 96. Bristol-Myers Squibb Description and Business Overview

Table 97. Bristol-Myers Squibb Pediatric Medicines Sales (Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 98. Bristol-Myers Squibb Pediatric Medicines Product

Table 99. Bristol-Myers Squibb Recent Developments/Updates

Table 100. Cipla Corporation Information

Table 101. Cipla Description and Business Overview

Table 102. Cipla Pediatric Medicines Sales (Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 103. Cipla Pediatric Medicines Product

Table 104. Cipla Recent Developments/Updates

Table 105. Eisai Pharmaceuticals Corporation Information

Table 106. Eisai Pharmaceuticals Description and Business Overview

Table 107. Eisai Pharmaceuticals Pediatric Medicines Sales (Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 108. Eisai Pharmaceuticals Pediatric Medicines Product

Table 109. Eisai Pharmaceuticals Recent Developments/Updates

Table 110. Eli Lilly Corporation Information

Table 111. Eli Lilly Description and Business Overview

Table 112. Eli Lilly Pediatric Medicines Sales (Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 113. Eli Lilly Pediatric Medicines Product

Table 114. Eli Lilly Recent Developments/Updates

Table 115. F. Hoffman-La Roche Corporation Information

Table 116. F. Hoffman-La Roche Description and Business Overview

Table 117. F. Hoffman-La Roche Pediatric Medicines Sales (Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 118. F. Hoffman-La Roche Pediatric Medicines Product

Table 119. F. Hoffman-La Roche Recent Developments/Updates

Table 120. Glenmark Corporation Information

Table 121. Glenmark Description and Business Overview

Table 122. Glenmark Pediatric Medicines Sales (Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 123. Glenmark Pediatric Medicines Product

Table 124. Glenmark Recent Developments/Updates

Table 125. Helsinn Healthcare Corporation Information

Table 126. Helsinn Healthcare Description and Business Overview

Table 127. Helsinn Healthcare Pediatric Medicines Sales (Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 128. Helsinn Healthcare Pediatric Medicines Product

Table 129. Helsinn Healthcare Recent Developments/Updates

Table 130. Heron Therapeutics Corporation Information

Table 131. Heron Therapeutics Description and Business Overview

Table 132. Heron Therapeutics Pediatric Medicines Sales (Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 133. Heron Therapeutics Pediatric Medicines Product

Table 134. Heron Therapeutics Recent Developments/Updates

Table 135. Ipca Laboratories Corporation Information

Table 136. Ipca Laboratories Description and Business Overview

Table 137. Ipca Laboratories Pediatric Medicines Sales (Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 138. Ipca Laboratories Pediatric Medicines Product

Table 139. Ipca Laboratories Recent Developments/Updates

Table 140. Key Raw Materials Lists

Table 141. Raw Materials Key Suppliers Lists

Table 142. Pediatric Medicines Distributors List

Table 143. Pediatric Medicines Customers List

Table 144. Pediatric Medicines Market Trends

Table 145. Pediatric Medicines Market Drivers

Table 146. Pediatric Medicines Market Challenges

Table 147. Pediatric Medicines Market Restraints

Table 148. Research Programs/Design for This Report

Table 149. Key Data Information from Secondary Sources

Table 150. Key Data Information from Primary Sources

List of Figures

Figure 1. Product Picture of Pediatric Medicines

Figure 2. Global Pediatric Medicines Market Value Comparison by Type (2024-2030) & (US$ Million)

Figure 3. Global Pediatric Medicines Market Share by Type in 2023 & 2030

Figure 4. Enteral Product Picture

Figure 5. Parenteral Product Picture

Figure 6. Topical Product Picture

Figure 7. Global Pediatric Medicines Market Value Comparison by Application (2024-2030) & (US$ Million)

Figure 8. Global Pediatric Medicines Market Share by Application in 2023 & 2030

Figure 9. Hospital

Figure 10. Clinic

Figure 11. Family

Figure 12. Global Pediatric Medicines Revenue, (US$ Million), 2019 VS 2023 VS 2030

Figure 13. Global Pediatric Medicines Market Size (2019-2030) & (US$ Million)

Figure 14. Global Pediatric Medicines Sales (2019-2030) & (Units)

Figure 15. Global Pediatric Medicines Average Price (USD/Unit) & (2019-2030)

Figure 16. Pediatric Medicines Report Years Considered

Figure 17. Pediatric Medicines Sales Share by Manufacturers in 2023

Figure 18. Global Pediatric Medicines Revenue Share by Manufacturers in 2023

Figure 19. The Global 5 and 10 Largest Pediatric Medicines Players: Market Share by Revenue in 2023

Figure 20. Pediatric Medicines Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023

Figure 21. Global Pediatric Medicines Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Figure 22. North America Pediatric Medicines Sales Market Share by Country (2019-2030)

Figure 23. North America Pediatric Medicines Revenue Market Share by Country (2019-2030)

Figure 24. U.S. Pediatric Medicines Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 25. Canada Pediatric Medicines Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 26. Europe Pediatric Medicines Sales Market Share by Country (2019-2030)

Figure 27. Europe Pediatric Medicines Revenue Market Share by Country (2019-2030)

Figure 28. Germany Pediatric Medicines Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 29. France Pediatric Medicines Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 30. U.K. Pediatric Medicines Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 31. Italy Pediatric Medicines Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 32. Russia Pediatric Medicines Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 33. Asia Pacific Pediatric Medicines Sales Market Share by Region (2019-2030)

Figure 34. Asia Pacific Pediatric Medicines Revenue Market Share by Region (2019-2030)

Figure 35. China Pediatric Medicines Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 36. Japan Pediatric Medicines Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 37. South Korea Pediatric Medicines Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 38. India Pediatric Medicines Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 39. Australia Pediatric Medicines Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 40. Taiwan Pediatric Medicines Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 41. Indonesia Pediatric Medicines Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 42. Thailand Pediatric Medicines Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 43. Malaysia Pediatric Medicines Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 44. Philippines Pediatric Medicines Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 45. Latin America Pediatric Medicines Sales Market Share by Country (2019-2030)

Figure 46. Latin America Pediatric Medicines Revenue Market Share by Country (2019-2030)

Figure 47. Mexico Pediatric Medicines Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 48. Brazil Pediatric Medicines Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 49. Argentina Pediatric Medicines Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 50. Middle East & Africa Pediatric Medicines Sales Market Share by Country (2019-2030)

Figure 51. Middle East & Africa Pediatric Medicines Revenue Market Share by Country (2019-2030)

Figure 52. Turkey Pediatric Medicines Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 53. Saudi Arabia Pediatric Medicines Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 54. UAE Pediatric Medicines Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 55. Global Sales Market Share of Pediatric Medicines by Type (2019-2030)

Figure 56. Global Revenue Market Share of Pediatric Medicines by Type (2019-2030)

Figure 57. Global Pediatric Medicines Price (USD/Unit) by Type (2019-2030)

Figure 58. Global Sales Market Share of Pediatric Medicines by Application (2019-2030)

Figure 59. Global Revenue Market Share of Pediatric Medicines by Application (2019-2030)

Figure 60. Global Pediatric Medicines Price (USD/Unit) by Application (2019-2030)

Figure 61. Pediatric Medicines Value Chain

Figure 62. Pediatric Medicines Production Process

Figure 63. Channels of Distribution (Direct Vs Distribution)

Figure 64. Distributors Profiles

Figure 65. Bottom-up and Top-down Approaches for This Report

Figure 66. Data Triangulation

Figure 67. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

RELATED REPORTS

Global Endoparasiticide Market Research Report 2024

120 Pages

Type: Report

Code: QYRE-Auto-36H8345

Wed Apr 17 00:00:00 UTC 2024

Add to Cart

Global Herpes Zoster Treatment Market Research Report 2024

120 Pages

Type: Report

Code: QYRE-Auto-34R905

Mon Apr 15 00:00:00 UTC 2024

Add to Cart

Global SGLT2 Inhibitor Market Research Report 2024

120 Pages

Type: Report

Code: QYRE-Auto-2R9930

Mon Apr 15 00:00:00 UTC 2024

Add to Cart

Global Seasonal Affective Disorder Therapeutics Market Research Report 2024

120 Pages

Type: Report

Code: QYRE-Auto-34L14446

Mon Apr 15 00:00:00 UTC 2024

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions